Abiopharma

FDA approve ETHOSUXIMIDE

FDA approve IRBESARTAN

FDA approve HYDROCHLOROTHIAZIDE; IRBESARTAN

FDA approve CETIRIZINE HYDROCHLORIDE

FDA approve CYCLOSPORINE

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: HOOKIPA Pharma Inc. - Common Stock.

NASDAQ symbol attribute type Security_Name was changed. Previous value: HOOKIPA Pharma Inc. - Common Stock. New value: HOOKIPA Pharma Inc. - Common Stock.

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: HOOKIPA Pharma Inc. - Common Stock.

BioNTech Reaches Agreement to Receive a Non-exclusive License for mRNA-based COVID-19 and/or Influenza Products and Resolve Patent Litigation with CureVac and GSK

Smith+Nephew PLC Notification

Riverstone Holdings Limited - Announcement

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

New Form S-3MEF - ASSEMBLY BIOSCIENCES, INC. Filed: 2025-08-07 AccNo: 0001193125-25-175697 Size: 244 KB